Researchers
-
Alejandro Fernández Simon
Digestive
-
Alex Blasco
Digestive
-
Alfredo Mata
Digestive
Phd -
Anna Bargallo
Digestive
Phd -
Carlos Hernández Ballesteros
Digestive
-
Celia Vasconez Peña
Digestive
-
David Barquero
Digestive
-
Eva Erice
Digestive
Phd -
Marta Martín Llahí
Digestive
Phd -
Mercè Navarro
Digestive
-
Orlando García Bosch
Digestive
Phd -
Xavier Ariza
Digestive
Phd
Contact the group
Form-
Barquero D, González V, García O, Fernández A, Blasco A, Navarro M, Bargalló A, Martín M, Erice E, Ariza X, Hernández C, Vascónez C, Martín-Baranera M, Castellví J, Mata A. 326/20
Ways to perform an endoscopic tattoo. prospective and randomized study in patients with colorectal neoplasm.
Rev Esp Enferm Dig 2020 Dec 1.
-
Barquero D, González V, García O, Fernández A, Blasco A, Navarro M, Bargalló A, Martín M, Erice E, Ariza X, Hernández C, Vascónez C, Martín-Baranera M, Castellví J, Mata A. 326/20
Ways to perform an endoscopic tattoo. prospective and randomized study in patients with colorectal neoplasm.
Rev Esp Enferm Dig 2020 Dec 1.
-
Barquero D, González V, García O, Fernández A, Blasco A, Navarro M, Bargalló A, Martín M, Erice E, Ariza X, Hernández C, Vascónez C, Martín-Baranera M, Castellví J, Mata A. 326/20
Ways to perform an endoscopic tattoo. prospective and randomized study in patients with colorectal neoplasm.
Rev Esp Enferm Dig 2020 Dec 1.
-
Barquero D, González V, García O, Fernández A, Blasco A, Navarro M, Bargalló A, Martín M, Erice E, Ariza X, Hernández C, Vascónez C, Martín-Baranera M, Castellví J, Mata A. 326/20
Ways to perform an endoscopic tattoo. prospective and randomized study in patients with colorectal neoplasm.
Rev Esp Enferm Dig 2020 Dec 1.
-
Cañete F, Mañosa M, Pérez-Martínez I, Barreiro-de Acosta M, González-Sueyro RC, Nos P, Iglesias-Flores E, Gutiérrez A, Bujanda L, Gordillo J, Ríos León R, Casanova MJ, Villoria A, Rodríguez -Lago I, López Serrano P, García-Herola A, Ramírez-de la Piscina P, Navarro-Llavat M, Taxonera C, Barrio J, Ramos J, Navarro P, Benítez-Leiva O, Calafat M, Domènech E, INFLIRECU study 205/20
Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis.
Clin Transl Gastroenterol. 2020 Aug;11(8):e00218.
-
Guasch M, Cañete F, Ordás I, Iglesias-Flores E, Clos A, Gisbert JP, Taxonera C, Vera I, Mínguez M, Guardiola J, Rivero M, Nos P, Gomollón F, Barrio J, de Francisco R, López- Sanromán A, Martín-Arranz MD, Garcia-Planella E, Camargo R, García-López S, de Castro L, Calvet X, Esteve M, Mañosa M, Domènech E, GETECCU-ENEIDA registry (Navarro-Llavat M) 212/20
Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents.
J Gastroenterol Hepatol. 2020 Dec;35(12):2080-2087.
-
Bassegoda O, Huelin P, Ariza X, Solé C, Juanola A, Gratacós-Ginès J, Carol M, Graupera I, Pose E, Napoleone L, Albertos S, de Prada G, Cervera M, Fernández J, Fabrellas N, Poch E , Solà E, Ginès P. 217/20
Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes.
J Hepatol. 2020 Jun;72(6):1132-1139.
-
Casanova MJ, Chaparro M, Mínguez M, Ricart E, Taxonera C, García-López S, Guardiola J, López-San Román A, Iglesias E, Beltrán B, Sicilia B, Vera MI, Hinojosa J, Riestra S, Domènech E, Calvet X, Lázaro Pérez-Calle J, Martín-Arranz MD, Aldeguer X, Rivero M, Monfort D, Barrio J, Esteve M, Márquez L, Lorente R, García-Planella E, de Castro L, Bermejo F, Merino O, Rodríguez-Pérez A, Martínez-Montiel P, Van Domselaar M, Alcaín G, Domínguez-Cajal M, Muñoz C, Gomollón F, Fernández-Salazar L, García-Sepulcre MF, Rodríguez-Lago I, Gutiérrez A, Argüelles-Arias F , Rodriguez C, Rodriguez GE, Bujanda L, Llaó J, Varela P, Ramos L, Huguet JM, Almela P, Romero P, Navarro-Llavat M, Abad A, Ramírez-de la Piscina P , Lucendo AJ, Sesé E, Madrigal RE, Charro M, García-Herola A, Pajares R, Khorrami S, Gisbert JP. 225/20
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
Inflamm Bowel Dis. 2020 Mar 4;26(4):606-616.
-
Algaba A, Guerra I, Ricart E, Iglesias E, Mañosa M, Gisbert JP, Guardiola J, Mínguez M, Castro B, de Francisco R, Nos P, Bertoletti F, Mesonero F, Barrio J, Martín-Arranz MD, Calvet X , García-López S, Sicilia B, Alcaín G, Esteve M, Marquez L, Piqueras M, Jiménez L, Perez-Calle JL, Bujanda L, García-Sepulcre M, Fernández A, Moraleja I, Lorente RH, García-Bosch O , Lambán A, Blázquez I, Rodríguez E, Huguet JM, Lucendo AJ, Almela P, Busquets D, Ramírez de la Piscina P, Pérez M, Domenech E, Bermejo F, Spanish GETECCU Group (ENEIDA Project). 241/20
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.
Dig Dis Sci. 2020 Jul 15.
-
Barquero D, González V, García O, Fernández A, Blasco A, Navarro M, Bargalló A, Martín M, Erice E, Ariza X, Hernández C, Vascónez C, Martín-Baranera M, Castellví J, Mata A. 326/20
Ways to perform an endoscopic tattoo. prospective and randomized study in patients with colorectal neoplasm.
Rev Esp Enferm Dig 2020 Dec 1.
Projects
-
Digestive
Researcher
- Year 2020
- HSDMB
Discovery: Pentax' Computer-aided Detection to Improve Adenoma Detection in a Real-time Setting - The Discovery II Study.
-
DISTRICT ATTORNEY:
Radboudumc
-
TYPE E:
PS
-
Digestive
Researcher
- Year 2020
- HSDMB
Pan-EU real-world experience with Imraldi® "PROPER",
-
DISTRICT ATTORNEY:
Biogen International GmbH.
-
TYPE E:
EPA-SP
-
Digestive
Researcher
- Year 2020
- HSDMB
Efficacy of the combination of simvastatin and rifaximin in patients with decompensated cirrhosis to prevent the development of ACLF, a double-blind, placebo-controlled, multicenter randomized clinical trial.
-
DISTRICT ATTORNEY:
IDIBAPS (Institute of Biomedical Research August Pi i Sunyer)
-
TYPE E:
RD2015
-
- Year 2020
- HSDMB
Discovery: Pentax' Computer-aided Detection to Improve Adenoma Detection in a Real-time Setting - The Discovery II Study.
-
DISTRICT ATTORNEY:
Radboudumc
-
TYPE E:
P.S
-
- Year 2020
- HSDMB
Pan-EU real-world experience with Imraldi® "PROPER",
-
DISTRICT ATTORNEY:
Biogen International GmbH.
-
TYPE E:
EPA-SP
-
- Year 2020
- HSDMB
Efficacy of the combination of simvastatin and rifaximin in patients with decompensated cirrhosis to prevent the development of ACLF, a double-blind, placebo-controlled, multicenter randomized clinical trial.
-
DISTRICT ATTORNEY:
IDIBAPS (Institute of Biomedical Research August Pi i Sunyer)
-
TYPE E:
RD2015
-
Digestive
Researcher
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Effectiveness and tolerability of ustekinumab in clinical practice in patients with active Crohn's disease
-
DISTRICT ATTORNEY:
Janssen Cilag, Spain
-
TYPE E:
EPA-OD
-
Digestive
Researcher
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Albumin for the management of hypervolemic hyponatremia in patients with decompensated cirrhosis. Concept study.
-
DISTRICT ATTORNEY:
Clinical Foundation for Biomedical Research
-
TYPE E:
RD2015
-
Digestive
Researcher
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Study of clinical and virological factors associated with virological control after withdrawal of antiviral treatment in patients with HBeAg-negative chronic hepatitis.
-
DISTRICT ATTORNEY:
Clinical Foundation for Biomedical Research
-
TYPE E:
PI
-
Digestive
Researcher
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Protocol for the detection of previously unknown liver disease in hospitalized patients with alcohol use disorder.
-
DISTRICT ATTORNEY:
Marta Martin
-
TYPE E:
PI
- Digestive Endoscopy
- Inflammatory bowel disease
